View Older Stories View More Recent Stories
-
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
-
Humana (HUM) Announces CFO Transition
-
Is Trump 2.0 good or bad for healthcare stocks?
-
RBC Capital Reiterates Outperform Rating on Humana (HUM), 'Peer's favorable stars ruling bodes well for HUM'
-
Trump picks RFK Jr for HHS — Here are potential policy implications
-
Cigna Corp. (CI) is not pursuing a combination with Humana (HUM)
-
BofA Securities Upgrades Humana (HUM) to Neutral, 'risk reward improves under new administration'
-
UnitedHealth Group (UNH), Humana (HUM) gain as Bernstein says Trump win positive for MCOs
-
Humana (HUM) Tops Q3 EPS by 78c; offers guidance
-
Humana (HUM) call put ratio 3.8 calls to 1 put into quarter results
-
Humana (HUM) and Longevity Health Multi-State Agreement Expands Access to Humana Together in Health Special Needs Plans
-
Humana (HUM) Elects Gordon Smith to Board of Directors
-
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
-
Centene (CNC) on watch on vague chatter
-
Humana (HUM) call put ratio 1 call to 2 puts into Cigna (CI) revives merger talks with Humana, Bloomberg reports
-
Cigna Corp. (CI) Is Said To Resume Merger Discussions With Humana (HUM) - Bloomberg
-
Humana (HUM): CarePlus Announces Medicare Advantage Plan Offerings for 2025
-
Keybanc Starts Humana (HUM) at Sector Perform
-
Humana (HUM) call put ratio 1.5 calls to 1 put on 38K contracts
-
After-hours movers: Humana, Mobileye, Triumph Group, Aehr Test Systems
-
Humana (HUM) Shares Drop as Medicare Releases Finial Quality Ratings - Bloomberg
-
Humana (HUM) PT Lowered to $265 at RBC Capital
-
Bernstein SocGen Group Upgrades Humana (HUM) to Outperform
-
TD Cowen Downgrades Humana (HUM) to Hold
-
Jefferies Downgrades Humana (HUM) to Hold
-
Piper Sandler Downgrades Humana (HUM) to Neutral
-
Raymond James Reiterates Market Perform Rating on Humana (HUM)
-
Wells Fargo Reiterates Overweight Rating on Humana (HUM)
-
Bernstein SocGen Group Reiterates Market Perform Rating on Humana (HUM)
-
Barclays Reiterates Overweight Rating on Evolent Health (EVH)
-
BofA Securities Downgrades Humana (HUM) to Underperform
-
Humana (HUM) January 330 puts active as share price down 12%
-
TD Cowen Reiterates Buy Rating on Humana (HUM)
-
Barclays Takeaways from Humana (HUM) Mgmt Call
-
JPMorgan Reviews Impact to Evolent Health (EVH) Amid Humana (HUM) News, Shares Gaining off LOD
-
Morgan Stanley Reiterates Equal-weight Rating on Humana (HUM)
-
Leerink Partners Downgrades Humana (HUM) to Market Perform, 'Visibility into Recovery Diminished'
-
JPMorgan on Humana (HUM): 'We believe that HUM will need to speak to the general impact of the potential reduction in stars for 2026'
-
BTIG Comments on Humana (HUM)
-
Stephens Downgrades Humana (HUM) to Equal Weight
-
Mizuho Trade Desk Comments on 'Supernova' Blowup at Humana (HUM): 'it is very likely the financials are impaired especially into FY26'
-
Leerink on Humana (HUM): 'Broad-Based Benefit Cuts Evident within Plan Finder for 2025'
-
Wolfe Comments on Humana (HUM): 'The logic path that points to trouble at HUM began w/the co. being non-responsive on Stars'
-
Barclays on Humana (HUM): 'If Plan Finder ratings are correct, the earnings impact to HUM would be significant'
-
Humana (HUM) falls after preliminary Medicare Advantage data
-
Humana (HUM) Sinks After Issuing Update on Medicare Advantage Plans for 2025
-
Jefferies Reiterates Buy Rating on Humana (HUM)
-
Humana (HUM) PT Raised to $400 at RBC Capital
-
Humana (HUM) intends to reaffirm its guidance
-
Midday movers: Microsoft, Pinterest, Humana fall; AMD, Nvidia and Starbucks rise
